Brief: Regent Pacific Updates On Operations On Fortacin
14/12/2020 09:49
Dec 14 (Reuters) - Regent Pacific Group Ltd 0575.HK :
* REGENT PACIFIC - ORIENT EUROPHARMA RECEIVED MARKETING
AUTHORISATION APPROVAL FOR TAIWAN FROM TAIWAN FOOD AND DRUG
ADMINISTRATION
* REGENT PACIFIC - NOTES ORIENT EUROPHARMA EXPECTS TO LAUNCH
FORTACIN IN TAIWAN, HONG KONG AND MACAU IN 2021
Source text for Eikon: ID:nHKS8VHG5k
Further company coverage: 0575.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Regent Pacific
See all newsBrief: Regent Pacific Says SenstendTM Approved By NMPA For Premature Ejaculation In China
Brief: Regent Pacific Says Deep Longevity To Launch U.S. Expansion In Q1 2026
Brief: Regent Pacific Shall Allot And Issue 63.4 Million Shares At Hk$0.485 Per Share
Brief: Regent Pacific Announces Submission Of Senstend New Drug Application To NMPA In China
Brief: Regent Pacific Enters Manufacturing And Supply Agreement For SENSTEND